InnoCare Pharma's market value is the price at which a share of InnoCare Pharma trades on a public exchange. It measures the collective expectations of InnoCare Pharma Limited investors about its performance. InnoCare Pharma is trading at 2.05 as of the 27th of December 2025. This is a 3.76 percent decrease since the beginning of the trading day. The stock's lowest day price was 2.05. With this module, you can estimate the performance of a buy and hold strategy of InnoCare Pharma Limited and determine expected loss or profit from investing in InnoCare Pharma over a given investment horizon. Check out InnoCare Pharma Correlation, InnoCare Pharma Volatility and InnoCare Pharma Alpha and Beta module to complement your research on InnoCare Pharma.
Please note, there is a significant difference between InnoCare Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if InnoCare Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InnoCare Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
InnoCare Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to InnoCare Pharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of InnoCare Pharma.
0.00
10/28/2025
No Change 0.00
0.0
In 2 months and 2 days
12/27/2025
0.00
If you would invest 0.00 in InnoCare Pharma on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding InnoCare Pharma Limited or generate 0.0% return on investment in InnoCare Pharma over 60 days. InnoCare Pharma is related to or competes with Shanghai Junshi, Genscript Biotech, ALK Abell, Laboratorios Farmaceuticos, Zealand Pharma, Camurus AB, and Fielmann Aktiengesellscha. InnoCare Pharma Limited, a clinical stage biopharmaceutical company, focuses on discovering, developing, and commerciali... More
InnoCare Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure InnoCare Pharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess InnoCare Pharma Limited upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for InnoCare Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as InnoCare Pharma's standard deviation. In reality, there are many statistical measures that can use InnoCare Pharma historical prices to predict the future InnoCare Pharma's volatility.
InnoCare Pharma holds Efficiency (Sharpe) Ratio of -0.17, which attests that the entity had a -0.17 % return per unit of risk over the last 3 months. InnoCare Pharma exposes nineteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out InnoCare Pharma's Market Risk Adjusted Performance of (0.70), standard deviation of 3.72, and Risk Adjusted Performance of (0.11) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.88, which attests to possible diversification benefits within a given portfolio. InnoCare Pharma returns are very sensitive to returns on the market. As the market goes up or down, InnoCare Pharma is expected to follow. At this point, InnoCare Pharma has a negative expected return of -0.63%. Please make sure to check out InnoCare Pharma's variance, skewness, as well as the relationship between the Skewness and day median price , to decide if InnoCare Pharma performance from the past will be repeated at some point in the near future.
Auto-correlation
0.38
Below average predictability
InnoCare Pharma Limited has below average predictability. Overlapping area represents the amount of predictability between InnoCare Pharma time series from 28th of October 2025 to 27th of November 2025 and 27th of November 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of InnoCare Pharma price movement. The serial correlation of 0.38 indicates that just about 38.0% of current InnoCare Pharma price fluctuation can be explain by its past prices.
Correlation Coefficient
0.38
Spearman Rank Test
-0.27
Residual Average
0.0
Price Variance
0.0
InnoCare Pharma lagged returns against current returns
Autocorrelation, which is InnoCare Pharma pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting InnoCare Pharma's pink sheet expected returns. We can calculate the autocorrelation of InnoCare Pharma returns to help us make a trade decision. For example, suppose you find that InnoCare Pharma has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
InnoCare Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If InnoCare Pharma pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if InnoCare Pharma pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in InnoCare Pharma pink sheet over time.
Current vs Lagged Prices
Timeline
InnoCare Pharma Lagged Returns
When evaluating InnoCare Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of InnoCare Pharma pink sheet have on its future price. InnoCare Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, InnoCare Pharma autocorrelation shows the relationship between InnoCare Pharma pink sheet current value and its past values and can show if there is a momentum factor associated with investing in InnoCare Pharma Limited.
Other Information on Investing in InnoCare Pink Sheet
InnoCare Pharma financial ratios help investors to determine whether InnoCare Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in InnoCare with respect to the benefits of owning InnoCare Pharma security.